Dechu Puliyanda, United States
Successful use of daratumumab (Anti-CD38) for the treatment of pediatric post-transplant proteinuric diseases: A case series
Dr. Longshan Liu, People's Republic of China
Impaired renal function at 1-year after for-cause biopsy affected long-term graft survival in pediatric kidney transplant recipients.